认知能力下降是否会影响手语?
Alice Naomi Preti1, Lorenzo Diana2, Rita Castaldo3
1School of Medicine and Surgery, PhD Program in Neuroscience, University of Milano-Bicocca, Monza, Italy. a.preti5@campus.unimib.it.
Aging clinical and experimental research
|September 3, 2023
概括
与健康个体相比,手写签名在阿尔茨海默病 (AD) 和前性痴呆症 (FTD) 患者中几乎没有变化. 这表明签名是这些神经退行性疾病认知衰退的不可靠指标.
科学领域:
- 神经学 神经学
- 认知科学 认知科学
- 法医科学 法医科学 法医科学
背景情况:
- 神经退行性疾病如阿尔茨海默氏症 (AD) 和前性痴呆症 (FTD) 可以影响运动技能和认知功能.
- 手写的签名需要精细运动控制和认知处理,这使得它们对神经系统变化有潜在的敏感性.
研究的目的:
- 研究AD和FTD患者手写签名的变化.
- 要确定使用基于评分者的方法进行的签名分析是否可以作为神经退行症的指标.
主要方法:
- 四位独立评价者评估了103名AD/FTD患者和31名健康对照 (HC) 的签名对.
- 签名收集的平均距离是5年,每个患者组都有一次预诊断.
- 评级人员使用0-1级来判断相似性/差异性,并确定特定特征的变化 (例如空间布局,字母形状).
主要成果:
- 在36%的AD患者和44%的FTD患者中报告了标志性变化,而在HC患者中则为17%.
- 在患者组和HC之间发现了报告变化的显著差异 (p < .01).
- 对于痴呆症患者来说,没有识别出独特的特征变化标志物,变化与临床/人口因素无关.
结论:
- 手写的签名在神经退行性疾病和正常衰老中表现出对变化的抵抗力.
- 对签名变化的主观评估是AD和FTD认知状态的不可靠指标.
更多相关视频
相关概念视频
Cognitive Development During Adulthood
155
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
155
Language and Cognition
374
Language serves as a bridge between ideas and communication, influencing how individuals perceive and interact with the world. Psychologists have long debated whether language shapes thought or vice versa. This discussion gained grip with Edward Sapir and Benjamin Lee Whorf in the 1940s, who proposed that language determines thought, a concept known as linguistic determinism. They suggested that the vocabulary and structure of a language influence how its speakers think and perceive reality.
374
Negative and Cognitive Symptoms of Schizophrenia
83
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
83
Dementia
139
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
139
Interference and Decay
165
Forgetting is a complex cognitive phenomenon influenced by several factors, among which interference and decay are particularly prominent. These processes explain why individuals often struggle to retrieve specific information from memory, leading to lapses in recall that can be observed in everyday situations.
Interference occurs when competing memories hinder the retrieval of particular information. It can be classified into two types: proactive and retroactive interference. Proactive...
Interference occurs when competing memories hinder the retrieval of particular information. It can be classified into two types: proactive and retroactive interference. Proactive...
165
Alzheimer's Disease: Overview
517
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
517


